A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults
Fernando Jimenez-Cruz, Abel Jasovich, Jaime Andrés Cajigas Plata et al. · Urology · 2002
Cited by 50 works. doi:10.1016/s0090-4295(02)01664-3
Authors
- Fernando Jimenez-Cruz
- Abel Jasovich
- Jaime Andrés Cajigas Plata
- Qi Jiang
- Danielle Imbeault
- Gail L. Woods
- Richard Gesser
References
- Some Methods for Strengthening the Common χ 2 Tests
- Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women
- Urinary Tract Infection
- Increasing Prevalence of Antimicrobial Resistance Among Uropathogens Causing Acute Uncomplicated Cystitis in Women
- Management of Urinary Tract Infections in Adults
- Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract Infection
- Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997
- Urinary Tract Infection: Economic Considerations
- In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia
- In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers